Hwang Subin, Kang Danbee, Park Hyejeong, Kim Youngha, Guallar Eliseo, Jeon Junseok, Lee Jung-Eun, Huh Wooseong, Suh Gee-Young, Cho Juhee, Jang Hye-Ryoun
Department of Internal Medicine, Seoul Paik Hospital, Inje University School of Medicine, Seoul 04551, Korea.
Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06531, Korea.
J Clin Med. 2022 Apr 24;11(9):2392. doi: 10.3390/jcm11092392.
The outcomes depending on the type of renal replacement therapy (RRT) or pre-existing kidney disease in critically ill patients with acute kidney injury (AKI) have not been fully elucidated. All adult intensive care unit patients with AKI in Korea from 2008 to 2015 were screened. A total of 124,182 patients, including 21,165 patients with pre-existing kidney disease, were divided into three groups: control (no RRT), dialysis, and continuous RRT (CRRT). In-hospital mortality and progression to end-stage kidney disease (ESKD) were analyzed according to the presence of pre-existing kidney disease. The CRRT group had a higher risk of in-hospital mortality. Among the patients with pre-existing kidney disease, the dialysis group had a lower risk of in-hospital mortality compared to other groups. The risk of ESKD was higher in the dialysis and CRRT groups compared to the control group. In the CRRT group, the risk of ESKD was even higher in patients without pre-existing kidney disease. Although both dialysis and CRRT groups showed a higher incidence of ESKD, in-hospital mortality was lower in the dialysis group, especially in patients with pre-existing kidney disease. Our study supports that RRT and pre-existing kidney disease may be important prognostic factors for overall and renal outcomes in patients with AKI.
在急性肾损伤(AKI)的危重症患者中,取决于肾脏替代治疗(RRT)类型或既往存在的肾脏疾病的预后尚未完全阐明。对2008年至2015年韩国所有患有AKI的成人重症监护病房患者进行了筛查。总共124,182例患者,包括21,165例既往有肾脏疾病的患者,被分为三组:对照组(未进行RRT)、透析组和连续性肾脏替代治疗(CRRT)组。根据是否存在既往肾脏疾病分析住院死亡率和进展为终末期肾病(ESKD)的情况。CRRT组住院死亡风险更高。在既往有肾脏疾病的患者中,透析组的住院死亡风险低于其他组。与对照组相比,透析组和CRRT组的ESKD风险更高。在CRRT组中,无既往肾脏疾病的患者ESKD风险更高。尽管透析组和CRRT组的ESKD发病率均较高,但透析组的住院死亡率较低,尤其是在既往有肾脏疾病的患者中。我们的研究支持RRT和既往存在的肾脏疾病可能是AKI患者总体和肾脏预后的重要预后因素。